{"DataElement":{"publicId":"3128032","version":"1","preferredName":"Chronic Lymphocytic Leukemia Symptom Type","preferredDefinition":"A description of the chronic lymphocytic leukemia symptoms.","longName":"3128024v1.0:3128026v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3128024","version":"1","preferredName":"Chronic Lymphocytic Leukemia Symptom","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003_An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","longName":"2725209v1.0:2425598v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2725209","version":"1","preferredName":"CLL","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003","longName":"C3163","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44C0D2C6-68CA-5D0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-27","modifiedBy":"ONEDATA","dateModified":"2008-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2425598","version":"1","preferredName":"Symptom","preferredDefinition":"An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","longName":"C4876","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"049B5946-27F3-2FE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-02","endDate":null,"createdBy":"PWEST","dateCreated":"2005-11-02","modifiedBy":"ONEDATA","dateModified":"2005-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7CB99B-F630-968C-E040-BB89AD436BE2","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3128026","version":"1","preferredName":"Chronic Lymphocytic Leukemia Symptom Type","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003_An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain._Type; a subdivision of a particular kind of thing.","longName":"3128026v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"B","valueDescription":"B","ValueMeaning":{"publicId":"3128028","version":"1","preferredName":"B","longName":"3128028","preferredDefinition":"Unexplained weight loss of greater than 10 percent of body weight in six months before treatment; unexplained fever greater than 38 degrees celcius; or, night sweats.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7C9FB4-DE95-762F-E040-BB89AD431145","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8D7C9FB4-DEAE-762F-E040-BB89AD431145","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"ONEDATA","dateModified":"2010-08-10","deletedIndicator":"No"},{"value":"A","valueDescription":"A","ValueMeaning":{"publicId":"3192737","version":"1","preferredName":"A","longName":"3192737","preferredDefinition":"None of the following: Unexplained weight loss of greater than 10 percent of body weight in six months before treatment; unexplained fever greater than 38 degrees celcius; or, night sweats.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CCD89D2-87A5-1CF8-E040-BB89AD430FBC","latestVersionIndicator":"Yes","beginDate":"2011-02-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CCD89D2-87BD-1CF8-E040-BB89AD430FBC","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-21","modifiedBy":"ONEDATA","dateModified":"2011-02-21","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B785240A-AD3C-A514-E040-BB89AD436782","beginDate":"2010-08-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3128025","version":"1","preferredName":"CLL Symptom Type","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003:An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.:Type; a subdivision of a particular kind of thing.","longName":"C3163:C4876:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7C9FB4-DE48-762F-E040-BB89AD431145","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"ONEDATA","dateModified":"2010-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7C9FB4-DE59-762F-E040-BB89AD431145","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964930","version":"1","longName":"2013r1: CLL Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cll_base_diag_dx_symptoms","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedObservationResult:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What were the chronic lymphoc","type":"Preferred Question Text","description":"What were the chronic lymphocytic leukemia symptoms?","url":null,"context":"NHLBI"},{"name":"What were the disease symptoms?","type":"Alternate Question Text","description":"What were the disease symptoms?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:3128032","type":"BRIDG Mapping Path","description":"PerformedObservationResult.value [symptom] WHERE PerformedObservationResult [symptom] > AssessResultRelationship > PerformedObservation [assessment] > DefinedObservation.nameCode = \"assess symptoms for possible diagnosis\" AND PerformedObservation [assessment] > PerformfedDiagnosis.value = \"lymphocytic leukemia\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7D5A9E-53D9-6698-E040-BB89AD433DE2","latestVersionIndicator":"Yes","beginDate":"2010-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-10","modifiedBy":"KUMMEROA","dateModified":"2021-03-19","changeDescription":".1/2/14mn-added Bridg info. 2021-3-19 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}